E161 | ±â´ÉÀû ºñ°íÀν¶¸°Ç÷¼º ÀúÇ÷´ç | Functional nonhyperinsulinaemic hypoglycaemia |
|
E161 | °íÀν¶¸°Áõ NOS | Hyperinsulinism NOS |
|
E161 | ±â´É¼º °íÀν¶¸°Áõ | Functional hyperinsulinism |
|
E161 | Ãéµµº£Å¸¼¼Æ÷ÀÇ Áõ½Ä NOS | Hyperplasia of pancreatic islet beta cells NOS |
|
E161 | ÀúÇ÷´çÈÄ È¥¼ö ³úº´Áõ | Posthypoglycaemic coma encephalopathy |
|
E162 | »ó¼¼ºÒ¸íÀÇ ÀúÇ÷´ç | Hypoglycemia, unspecified |
|
E163 | ±Û·çÄ«°ï °ú´ÙºÐºñ | Increased secretion of glucagon |
|
E163 | ±Û·çÄ«°ï ºÐºñ°ú´Ù¸¦ µ¿¹ÝÇÑ ÃéÀå³»ºÐºñ ¼¼Æ÷ÀÇ Áõ½Ä | Hyperplasia of pancreatic endocrine cells with glucagon excess |
|
E164 | °¡½ºÆ®¸°ÀÇ ÀÌ»óºÐºñ | Abnormal secretion of gastrin |
|
E164 | °í°¡½ºÆ®¸°Ç÷Áõ | Hypergastrinaemia |
|
E164 | Á¹¸°°Å-¿¤¸®½¼ ÁõÈıº | Zollinger-Ellison syndrome |
|
E168 | ±âŸ ¸í½ÃµÈ ÃéÀå³»ºÐºñÀÇ Àå¾Ö | Other specified disorders of pancreatic internal secretion |
|
E168 | ¼ºÀåÈ£¸£¸ó-¹æÃâÈ£¸£¸óÀÇ ³»ºÐºñÃéÀå¿¡¼ÀÇ °ú´ÙºÐºñ | Increased secretion from endocrine pancreas of growth hormone-releasing hormone |
|
E168 | ÃéÀåÆú¸®ÆéŸÀ̵åÀÇ ³»ºÐºñÃéÀå¿¡¼ÀÇ °ú´ÙºÐºñ | Increased secretion from endocrine pancreas of pancreatic polypeptide |
|
E168 | ¼ºÀåÈ£¸£¸ó¾ïÁ¦È£¸£¸óÀÇ ³»ºÐºñÃéÀå¿¡¼ÀÇ °ú´ÙºÐºñ | Increased secretion from endocrine pancreas of somatostatin |
|
E168 | Ç÷°üÈ°¼º-ÀåÆú¸®ÆéƼµåÀÇ ³»ºÐºñÃéÀå¿¡¼ÀÇ °ú´ÙºÐºñ | Other specified disorders of pancreatic internal secretion |
|
E169 | »ó¼¼ºÒ¸íÀÇ ÃéÀå³»ºÐºñ Àå¾Ö | Disorder of pancreatic internal secretion, unspecified |
|
E169 | Ãéµµ¼¼Æ÷Áõ½Ä NOS | Islet-cell hyperplasia NOS |
|
E169 | ÃéÀå³»ºÐºñ¼¼Æ÷ Áõ½Ä NOS | Pancreatic endocrine cell hyperplasia NOS |
|
E20 | ºÎ°©»ó¼±±â´ÉÀúÇÏÁõ | Hypoparathyroidism |
|